Skip to content

Depression: all studies

Page 800 of 1,034: studies 7,991 to 8,000 of 10,336, newest first. Back to the depression overview

Research

Mindfulness-Based Stress Reduction (MBSR) and Self Compassion (SC) Training for Parents of Children with Autism Spectrum Disorders: A Pilot Trial in Community Services in Spain

Children April 22, 2021 Liliana Paulina Rojas-Torres, Yurena Alonso-Esteban, María Fernanda López-Ramón et al.

This study aims to develop a clinical trial to test the efficacy of a mindfulness-based stress reduction (MBSR) and self-compassion (SC) program on self-reported values of anxiety, depression, and stress in parents of children with autism spectrum disorder (ASD) in primary school, in order to assess their integration into the framework of community intervention programs in Spain. Methods: A...

DOI: 10.3390/children8050316 (opens in new tab) Full text (opens in new tab) Mindfulness Autism spectrum disorders Parental stress Parent anxiety

Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions.

American Journal of Health-System Pharmacy April 22, 2021 Dimitri Ancedy, Maria Sebti, Martine Postaire et al. 7 citations

Ketamine is an anesthetic agent commonly used for the induction of anesthesia. Ketamine is also given to control pain, for treatment of posttraumatic stress disorder, and to induce bronchodilation in refractory asthma. Moreover, ketamine therapy is gaining ground as an intervention for patients with treatment-resistant depression and individuals who have depression with serious suicidal...

Mindfulness-based interventions: an overall review

British Medical Bulletin April 21, 2021 Dexing Zhang, Kam-Pui Lee, E Mák et al. 638 citations

INTRODUCTION: This is an overall review on mindfulness-based interventions (MBIs). SOURCES OF DATA: We identified studies in PubMed, EMBASE, CINAHL, PsycINFO, AMED, Web of Science and Google Scholar using keywords including 'mindfulness', 'meditation', and 'review', 'meta-analysis' or their variations. AREAS OF AGREEMENT: MBIs are effective for improving many biopsychosocial conditions,...

Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.

Frontiers in Pharmacology April 21, 2021 Daniel Perkins, Violeta Schubert, Hana Šimonová et al. 73 citations

Ayahuasca is a traditional plant decoction containing N,N-dimethyltryptamine (DMT) and various β-carbolines including harmine, harmaline, and tetrahydroharmine, which has been used ceremonially by Amazonian Indigenous groups for healing and spiritual purposes. Use of the brew has now spread far beyond its original context of consumption to North America, Europe, and Australia in neo-shamanic...

DOI: 10.3389/fphar.2021.623979 (opens in new tab) Full text (opens in new tab) Ayahuasca context Ayahuasca setting Ayahuasca environment Ayahuasca preparation +16

Mindfulness-based interventions for social anxiety disorder: A systematic review and meta-analysis.

Psychiatry Research April 20, 2021 Xiaoyu Liu, Peng Yi, Lijun Ma et al.

Various psychiatric disorders are treated with mindfulness-based interventions (MBIs), although the efficacy of MBIs in patients with social anxiety disorder (SAD) is unclear. In this meta-analysis, we investigated the efficacy of MBIs on SAD symptoms. Systematic searches were performed in various databases, and 11 eligible randomized controlled trials (RCTs) and 5 single-arm trials were...

Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial.

Psychotherapy and Psychosomatics April 19, 2021 Natalie L. Marchant, Thorsten Barnhofer, Roxane Coueron et al.

Introduction: Older adults experiencing subjective cognitive decline (SCD) have a heightened risk of developing dementia and frequently experience subclinical anxiety, which is itself associated with dementia risk. Objective: To understand whether subclinical anxiety symptoms in SCD can be reduced through behavioral interventions. Methods: SCD-Well is a randomized controlled trial designed to...

Symptom specificity of ayahuasca's effect on depressive symptoms

Journal of Psychedelic Studies April 19, 2021 Cody Gilbert, Mitch Earleywine, Maha N. Mian et al. 3 citations

Abstract Background Ayahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew. Aims We examined self-reported effects of ayahuasca on the individual symptoms of depression...

The effect of a mindfulness-based stress intervention on neurobiological and symptom measures in adolescents with early life stress: a randomized feasibility study

BMC Complementary Medicine and Therapies April 15, 2021 Zsofia P Cohen, Kelly T. Cosgrove, Elisabeth Akeman et al. 38 citations

BACKGROUND: Early life stress (ELS) has been linked to poor mental and physical health outcomes in adolescence and adulthood. Mindfulness reduces symptoms of depression and anxiety and improves cognitive and social outcomes in both youth and adults. However, little is known whether mindfulness can mitigate against the adverse neurobiological and psychological effects of ELS. This study aimed to...

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Molecular Psychiatry April 15, 2021 Jordi Bonaventura, Sherry Lam, Meghan L. Carlton et al. 266 citations

Ketamine, a racemic mixture of (S)-ketamine and (R)-ketamine enantiomers, has been used as an anesthetic, analgesic and more recently, as an antidepressant. However, ketamine has known abuse liability (the tendency of a drug to be used in non-medical situations due to its psychoactive effects), which raises concerns for its therapeutic use. (S)-ketamine was recently approved by the United...

Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.

Inflammatory bowel diseases April 13, 2021 G. Goren, D. Schwartz, M. Friger et al.

BACKGROUND Patients with Crohn disease have debilitating psychological symptoms, mental fatigue, and poor quality of life. Psychological intervention may improve these symptoms. METHODS We performed a randomized parallel-group physician-blinded trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) on quality of life and psychological symptoms in adults with...